City

Fullerton (1)

New York (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

Sponsor

National Cancer Institute (NCI) (1)

Stanford University (1)

Collaborator

Intervention

laboratory biomarker analysis (2)

best practice (1)

dasatinib (1)

ipilimumab (1)

pharmacological study (1)

supportive care (1)

survey administration (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

stage iv soft tissue sarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting

Acute Myeloid Leukemia
+66 more

Best Practice
+3 more

Fullerton, California

Virginia K Crosson Cancer Center

Jan 31, 2022

Gastrointestinal Stromal Tumor, Stage III Soft Tissue Sarcoma, Stage IV Soft Tissue Sarcoma Trial in New York (drug, biological,

Completed

Gastrointestinal Stromal Tumor
+2 more

Dasatinib
+3 more

New York, New York

Memorial Sloan-Kettering Cancer Center

Jan 9, 2017